NVDA Q3 Earnings Alert: Why our AI stock picker is still holding Nvidia stockRead More

REFILE-French body says Monsanto maize needs more study

Published 12/22/2009, 01:45 PM

(Refiles to fix typographical error in third paragraph)

PARIS, Dec 22 (Reuters) - More research is needed into Monsanto's genetically modified maize MON 810, the only biotech crop commercially grown in Europe, to assess its environmental impact, a French advisory body said.

The opinion given by biotech committee HCB, published on Tuesday, was requested by the French government, which last year banned cultivation of MON 810 citing environmental concerns.

In a debate about whether to renew the licence for the maize type, France and other European Union states have criticised as insufficient a favourable opinion in June from the European Food Safety Authority (EFSA).

HCB called for further studies to evaluate potential drawbacks in MON 810, such as damage to non-targeted insects or the development of resistance to the crop among targeted pests.

"The only way to highlight ... a significant increase or decrease in populations of non-targeted invertebrates is to implement monitoring over several years," the HCB said.

The committee also said more work was needed to establish the benefits of the maize type versus other growing techniques, especially in areas not significantly affected by the pests MON 810 was designed to resist.

The views of the committee would be presented by France in European discussions on MON 810, which are due to lead to a conclusion by EU technical representatives in February, an official at the French environment ministry said.

But HCB's paper also showed how divisive the issue is within France. A vote by a subcommittee made up of farm unions, environmental associations, scientific and parliamentary bodies, on the overall value of MON 810 showed a narrow majority of 14 to 11 saying the maize had more disadvantages than benefits.

In a separate opinion also released on Tuesday, French food safety body AFSSA reiterated that, like EFSA, it considered MON 810 to be as safe as conventional maize for human and animal health, although it also called for further research. (Reporting by Gus Trompiz, editing by Anthony Barker)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.